46 results on '"De Lorenzo D"'
Search Results
2. Impulsive-disinhibited personality and serotonin transporter gene polymorphisms: Association study in an inmate’s sample
- Author
-
Aluja, Anton, Garcia, Luis F., Blanch, Angel, De Lorenzo, D., and Fibla, Joan
- Published
- 2009
- Full Text
- View/download PDF
3. LONG-TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT)
- Author
-
Ferreri, A.J., primary, Sassone, M.C., additional, Angelillo, P., additional, Zaja, F., additional, Re, A., additional, Spina, M., additional, Di Rocco, A., additional, Fabbri, A., additional, Stelitano, C., additional, Frezzato, M., additional, Rusconi, C., additional, Zambello, R., additional, Arcari, A., additional, Bertoldero, G., additional, De Lorenzo, D., additional, Volpetti, S., additional, Calimeri, T., additional, Perrone, S., additional, Cecchetti, C., additional, Ciceri, F., additional, and Ponzoni, M., additional
- Published
- 2019
- Full Text
- View/download PDF
4. EP-1338: High precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion
- Author
-
Riva, G., primary, Timon, G., additional, Ciardo, D., additional, Bazani, A., additional, Maestri, D., additional, De Lorenzo, D., additional, Pansini, F., additional, Cambria, R., additional, Cattani, F., additional, Marvaso, G., additional, Zerini, D., additional, Rojas, D.P., additional, Volpe, S., additional, Golino, F., additional, Scroffi, V., additional, Fodor, C., additional, Petralia, G., additional, De Cobelli, O., additional, Orecchia, R., additional, and Jereczek-Fossa, B.A., additional
- Published
- 2017
- Full Text
- View/download PDF
5. A response to letter to the editor: A genetic-based algorithm for personalized resistance training
- Author
-
Jones, N., Kiely, J., Suraci, B., Collins, D., de Lorenzo, D., Pickering, Craig, Grimaldi, K.A, Jones, N., Kiely, J., Suraci, B., Collins, D., de Lorenzo, D., Pickering, Craig, and Grimaldi, K.A
- Published
- 2017
6. Recent progress in EC funded project HYTHEC on massive scale hydrogen production via thermochemical cycles
- Author
-
LE DUIGOU A, BORGARD J. M, LAROUSSE B, DOIZI D, ALLEN R, EWAN B, PRIESTMAN J, ELDER R, CERRI G, DE MARIA G, ROEB M, MONNERIE N, SATTLER C, BUENAVENTURA A, DE LORENZO D, DECHELOTTE S, BAUDOUIN O., SALVINI, Coriolano, GIOVANNELLI, AMBRA, AIChE, LE DUIGOU, A, BORGARD J., M, Larousse, B, Doizi, D, Allen, R, Ewan, B, Priestman, J, Elder, R, Cerri, G, Salvini, Coriolano, Giovannelli, Ambra, DE MARIA, G, Roeb, M, Monnerie, N, Sattler, C, Buenaventura, A, DE LORENZO, D, Dechelotte, S, and Baudouin, O.
- Published
- 2007
7. A response to letter to the editor: A genetic-based algorithm for personalized resistance training
- Author
-
Jones, N, primary, Kiely, J, additional, Suraci, B, additional, Collins, DJ, additional, de Lorenzo, D, additional, Pickering, C, additional, and Grimaldi, KA, additional
- Published
- 2017
- Full Text
- View/download PDF
8. A genetic-based algorithm for personalized resistance training
- Author
-
Jones, N., Kiely, J., Suraci, B., Collins, D., de Lorenzo, D., Pickering, Craig, Grimaldi, K.A., Jones, N., Kiely, J., Suraci, B., Collins, D., de Lorenzo, D., Pickering, Craig, and Grimaldi, K.A.
- Abstract
Association studies have identified dozens of genetic variants linked to training responses and sport-related traits. However, no intervention studies utilizing the idea of personalised training based on athlete’s genetic profile have been conducted. Here we propose an algorithm that allows achieving greater results in response to high- or low-intensity resistance training programs by predicting athlete’s potential for the development of power and endurance qualities with the panel of 15 performance-associated gene polymorphisms. To develop and validate such an algorithm we performed two studies in independent cohorts of male athletes (study 1: athletes from different sports (n=28); study 2: soccer players (n=39)). In both studies athletes completed an eight-week high- or low-intensity resistance training program, which either matched or mismatched their individual genotype. Two variables of explosive power and aerobic fitness, as measured by the countermovement jump (CMJ) and aerobic 3-min cycle test (Aero3) were assessed pre and post 8 weeks of resistance training. In study 1, the athletes from the matched groups (i.e. high-intensity trained with power genotype or low-intensity trained with endurance genotype) significantly increased results in CMJ (P=0.0005) and Aero3 (P=0.0004). Whereas, athletes from the mismatched group (i.e. high-intensity trained with endurance genotype or lowintensity trained with power genotype) demonstrated non-significant improvements in CMJ (P=0.175) and less prominent results in Aero3 (P=0.0134). In study 2, soccer players from the matched group also demonstrated significantly greater (P<0.0001) performance changes in both tests compared to the mismatched group. Among non- or low responders of both studies, 82% of athletes (both for CMJ and Aero3) were from the mismatched group (P<0.0001). Our results indicate that matching the individual’s genotype with the appropriate training modality leads to more effective resistance training. The
- Published
- 2016
9. MON-PP167: A Randomized Controlled Trial of a Gluten-Free Weight Loss Diet in HLA DQ2 or D8 Positive Subjects
- Author
-
Vranceanu, M., primary, De Lorenzo, D., additional, and Grimaldi, K.A., additional
- Published
- 2015
- Full Text
- View/download PDF
10. Miniaturized rigid probe driver with haptic loop control for neurosurgical interventions.
- Author
-
De Lorenzo, D., Manganelli, R., Dyagilev, I., Formaglio, A., De Momi, E., Prattichizzo, D., Shoham, M., and Ferrigno, G.
- Published
- 2010
- Full Text
- View/download PDF
11. Quantification of Structural Loading During Off-Road Cycling
- Author
-
De Lorenzo, D. S., primary and Hull, M. L., additional
- Published
- 1999
- Full Text
- View/download PDF
12. A Hub Dynamometer for Measurement of Wheel Forces in Off-Road Bicycling
- Author
-
De Lorenzo, D. S., primary and Hull, M. L., additional
- Published
- 1999
- Full Text
- View/download PDF
13. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
- Author
-
Fruzzetti, F, primary, de Lorenzo, D, additional, Parrini, D, additional, and Ricci, C, additional
- Published
- 1994
- Full Text
- View/download PDF
14. Navigation, Interference Suppression, and Fault Monitoring in the Sea-Based Joint Precision Approach and Landing System
- Author
-
Rife, J., Khanafseh, S., Pullen, S., De Lorenzo, D., Kim, Ung-Suok, Koenig, M., Chiou, Tsung-Yu, Kempny, B., and Pervan, B.
- Published
- 1968
- Full Text
- View/download PDF
15. MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study
- Author
-
Ilaria Francaviglia, Paolo Lopedote, Filippo Gagliardi, Fabio Ciceri, Sara Steffanoni, Rita Daverio, Teresa Calimeri, Elena Anghileri, Maria Rosa Terreni, Marianna Sassone, Roberto Furlan, Piera Angelillo, Vittoria Tarantino, Maurilio Ponzoni, Chiara Iacona, Claudio Tripodo, Cristina Belloni, Alessandro Gulino, Daniela De Lorenzo, Massimo Filippi, Marica Eoli, Elena Guggiari, Maria Giulia Cangi, Vittorio Martinelli, Massimo Locatelli, Annamaria Finardi, Andrés J.M. Ferreri, Andrea Falini, Nicoletta Anzalone, Marco Foppoli, Alessandro Nonis, Pietro Mortini, Claudio Doglioni, Angelo Diffidenti, Ferreri, A. J. M., Calimeri, T., Lopedote, P., Francaviglia, I., Daverio, R., Iacona, C., Belloni, C., Steffanoni, S., Gulino, A., Anghileri, E., Diffidenti, A., Finardi, A., Gagliardi, F., Anzalone, N., Nonis, A., Furlan, R., De Lorenzo, D., Terreni, M. R., Martinelli, V., Sassone, M., Foppoli, M., Angelillo, P., Guggiari, E., Falini, A., Mortini, P., Filippi, M., Tarantino, V., Eoli, M., Ciceri, F., Doglioni, C., Tripodo, C., Locatelli, M., Cangi, M. G., Ponzoni, M., Ferreri A.J.M., Calimeri T., Lopedote P., Francaviglia I., Daverio R., Iacona C., Belloni C., Steffanoni S., Gulino A., Anghileri E., Diffidenti A., Finardi A., Gagliardi F., Anzalone N., Nonis A., Furlan R., De Lorenzo D., Terreni M.R., Martinelli V., Sassone M., Foppoli M., Angelillo P., Guggiari E., Falini A., Mortini P., Filippi M., Tarantino V., Eoli M., Ciceri F., Doglioni C., Tripodo C., Locatelli M., Cangi M.G., and Ponzoni M.
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Lymphoma ,Biopsy ,Concordance ,interleukin-10 ,diffuse large B-cell lymphoma ,Mutation, Missense ,Central Nervous System Neoplasms ,03 medical and health sciences ,primary CNS lymphoma ,0302 clinical medicine ,Cerebrospinal fluid ,hemic and lymphatic diseases ,Biomarkers, Tumor ,TaqMan ,medicine ,Humans ,diffuse large B-cell lymphoma, interleukin-10, interleukin-6, MYD88 L265P mutation, primary CNS lymphoma ,Prospective cohort study ,Aged ,medicine.diagnostic_test ,business.industry ,interleukin-6 ,Primary central nervous system lymphoma ,Hematology ,Middle Aged ,medicine.disease ,Interleukin-10 ,Neoplasm Proteins ,MYD88 L265P mutation ,Amino Acid Substitution ,030220 oncology & carcinogenesis ,Myeloid Differentiation Factor 88 ,Female ,business ,Diffuse large B-cell lymphoma ,030215 immunology - Abstract
Reliable biomarkers are needed to avoid diagnostic delay and its devastating effects in patients with primary central nervous system (CNS) lymphoma (PCNSL). We analysed the discriminating sensitivity and specificity of myeloid differentiation primary response (88) (MYD88) L265P mutation (mut-MYD88) and interleukin-10 (IL-10) in cerebrospinal fluid (CSF) of both patients with newly diagnosed (n=36) and relapsed (n=27) PCNSL and 162 controls (118 CNS disorders and 44 extra-CNS lymphomas). The concordance of MYD88 mutational status between tumour tissue and CSF sample and the source of ILs in PCNSL tissues were also investigated. Mut-MYD88 was assessed by TaqMan-based polymerase chain reaction. IL-6 and IL-10 messenger RNA (mRNA) was assessed on PCNSL biopsies using RNAscope technology. IL levels in CSF were assessed by enzyme-linked immunosorbent assay. Mut-MYD88 was detected in 15/17 (88%) PCNSL biopsies, with an 82% concordance in paired tissue-CSF samples. IL-10 mRNA was detected in lymphomatous B cells in most PCNSL; expression of IL-6 transcripts was negligible. In CSF samples, mut-MYD88 and high IL-10 levels were detected, respectively, in 72% and 88% of patients with newly diagnosed PCNSL and in 1% of controls; conversely, IL-6 showed a low discriminating sensitivity and specificity. Combined analysis of MYD88 and IL-10 exhibits a sensitivity and specificity to distinguish PCNSL of 94% and 98% respectively. Similar figures were recorded in patients with relapsed PCNSL. In conclusion, high detection rates of mut-MYD88 and IL-10 in CSF reflect, respectively, the MYD88 mutational status and synthesis of this IL in PCNSL tissue. These biomarkers exhibit a very high sensitivity and specificity in detecting PCNSL both at initial diagnosis and relapse. Implications of these findings in patients with lesions unsuitable for biopsy deserve to be investigated.
- Published
- 2021
- Full Text
- View/download PDF
16. Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation
- Author
-
Eloise Scarano, Vittoria Tarantino, Sara Steffanoni, Piera Angelillo, Chiara Rusconi, C. Cecchetti, Maurilio Ponzoni, Marco Foppoli, Alessandro Re, Caterina Stelitano, Alessandro Nonis, Salvatore Perrone, Michele Spina, Stefano Volpetti, Maurizio Frezzato, Marianna Sassone, Renato Zambello, Alice Di Rocco, Annalisa Arcari, Fabio Ciceri, Andrés J.M. Ferreri, Alberto Fabbri, Daniela De Lorenzo, Francesco Zaja, Teresa Calimeri, Giovanni Bertoldero, Ferreri, Ajm, Sassone, M, Angelillo, P, Zaja, F, Re, A, Di Rocco, A, Spina, M, Fabbri, A, Stelitano, C, Frezzato, M, Volpetti, S, Zambello, R, Rusconi, C, De Lorenzo, D, Scarano, E, Arcari, A, Bertoldero, G, Nonis, A, Calimeri, T, Perrone, S, Cecchetti, C, Tarantino, V, Steffanoni, S, Foppoli, M, Ciceri, F, Ponzoni, M., Ferreri, A. J. M., Sassone, M., Angelillo, P., Zaja, F., Re, A., Di Rocco, A., Spina, M., Fabbri, A., Stelitano, C., Frezzato, M., Volpetti, S., Zambello, R., Rusconi, C., De Lorenzo, D., Scarano, E., Arcari, A., Bertoldero, G., Nonis, A., Calimeri, T., Perrone, S., Cecchetti, C., Tarantino, V., Steffanoni, S., Foppoli, M., and Ciceri, F.
- Subjects
Male ,Oncology ,Cancer Research ,Lymphoma ,Salvage therapy ,Angiogenesis Inhibitors ,0302 clinical medicine ,Autologous stem-cell transplantation ,80 and over ,cell of origin ,diffuse large B-cell lymphoma ,immunomodulators ,lenalidomide ,maintenance ,transformed high-grade lymphoma ,Aged, 80 and over ,immunomodulator ,Hematology ,General Medicine ,Middle Aged ,Prognosis ,Diffuse ,Survival Rate ,Local ,030220 oncology & carcinogenesis ,Female ,Lymphoma, Large B-Cell, Diffuse ,medicine.drug ,Adult ,medicine.medical_specialty ,Neutropenia ,Maintenance Chemotherapy ,03 medical and health sciences ,Chemoimmunotherapy ,Internal medicine ,Large B-Cell ,medicine ,Humans ,Autologous transplantation ,Aged ,Follow-Up Studies ,Lenalidomide ,Neoplasm Recurrence, Local ,Salvage Therapy ,Survival rate ,business.industry ,medicine.disease ,Neoplasm Recurrence ,business ,Diffuse large B-cell lymphoma ,030215 immunology - Abstract
We report final results of a phase II trial addressing efficacy and feasibility of lenalidomide maintenance in patients with chemosensitive relapse of diffuse large B-cell lymphoma (DLBCL) not eligible for or failed after autologous stem cell transplantation (ASCT). Patients with relapsed DLBCL who achieved at least a partial response to salvage chemoimmunotherapy were enrolled and treated with lenalidomide 25 mg/day for 21 of 28 days for 2 years or until progression or unacceptable toxicity. Primary endpoint was 1-year PFS. Forty-six of 48 enrolled patients were assessable. Most patients had IPI ≥2, advanced stage and extranodal disease before the salvage treatment that led to trial registration; 28 (61%) patients were older than 70 years. Lenalidomide was well tolerated. With the exception of neutropenia, grade-4 toxicities occurred in
- Published
- 2020
17. Facility Effluent Monitoring Plan for the uranium trioxide facility
- Author
-
De Lorenzo, D [Los Alamos Technical Associates, Inc., NM (United States)]
- Published
- 1993
- Full Text
- View/download PDF
18. Facility effluent monitoring plan for the plutonium-uranium extraction facility
- Author
-
De Lorenzo, D [Los Alamos Technical Associates, NM (United States)]
- Published
- 1993
- Full Text
- View/download PDF
19. Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial
- Author
-
Letterio S. Politi, Daniela De Lorenzo, Andrés J.M. Ferreri, Eltjona Rrapaj, Claudio Bordignon, Vittoria Tarantino, Fabio Ciceri, Angelo Corti, Eloise Scarano, Nicoletta Anzalone, Paolo Lopedote, Gian Marco Conte, Piera Angelillo, Maurilio Ponzoni, Marianna Sassone, Teresa Calimeri, Flavio Curnis, Federico Fallanca, Marco Foppoli, Alessandro Nonis, Giovanni Citterio, Dario Cattaneo, Elena Guggiari, Sara Steffanoni, Ferreri, A. J. M., Calimeri, T., Ponzoni, M., Curnis, F., Conte, G. M., Scarano, E., Rrapaj, E., De Lorenzo, D., Cattaneo, D., Fallanca, F., Nonis, A., Foppoli, M., Lopedote, P., Citterio, G., Politi, L. S., Sassone, M., Angelillo, P., Guggiari, E., Steffanoni, S., Tarantino, V., Ciceri, F., Bordignon, C., Anzalone, N., and Corti, A.
- Subjects
Oncology ,Vincristine ,medicine.medical_specialty ,Clinical Trials and Observations ,medicine.medical_treatment ,Recombinant Fusion Proteins ,NGR-hTNF ,Internal medicine ,hemic and lymphatic diseases ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Cyclophosphamide ,Lenalidomide ,Chemotherapy ,business.industry ,Tumor Necrosis Factor-alpha ,Standard treatment ,Primary central nervous system lymphoma ,Endothelial Cells ,Hematology ,medicine.disease ,Chemotherapy regimen ,Doxorubicin ,Prednisone ,Rituximab ,Neoplasm Recurrence, Local ,business ,medicine.drug - Abstract
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard treatment of diffuse large B-cell lymphoma (DLBCL). Primary DLBCL of the central nervous system (CNS) (primary central nervous system lymphoma [PCNSL]) is an exception because of the low CNS bioavailability of related drugs. NGR–human tumor necrosis factor (NGR-hTNF) targets CD13+ vessels, enhances vascular permeability and CNS access of anticancer drugs, and provides the rationale for the treatment of PCNSL with R-CHOP. Herein, we report activity and safety of R-CHOP preceded by NGR-hTNF in patients with PCNSL relapsed/refractory to high-dose methotrexate-based chemotherapy enrolled in a phase 2 trial. Overall response rate (ORR) was the primary endpoint. A sample size of 28 patients was considered necessary to demonstrate improvement from 30% to 50% ORR. NGR-hTNF/R-CHOP would be declared active if ≥12 responses were recorded. Treatment was well tolerated; there were no cases of unexpected toxicities, dose reductions or interruptions. NGR-hTNF/R-CHOP was active, with confirmed tumor response in 21 patients (75%; 95% confidence interval, 59%-91%), which was complete in 11. Seventeen of the 21 patients with response to treatment received consolidation (ASCT, WBRT, and/or lenalidomide maintenance). At a median follow-up of 21 (range, 14-31) months, 5 patients remained relapse-free and 6 were alive. The activity of NGR-hTNF/R-CHOP is in line with the expression of CD13 in both pericytes and endothelial cells of tumor vessels. High plasma levels of chromogranin A, an NGR-hTNF inhibitor, were associated with proton pump inhibitor use and a lower remission rate, suggesting that these drugs should be avoided during TNF-based therapy. Further research on this innovative approach to CNS lymphomas is warranted. The trial was registered as EudraCT: 2014-001532-11.
- Published
- 2020
20. Development and verification of process concepts for the splitting of sulphuric acid by concentrated solar radiation
- Author
-
Roeb, Martin, Noglik, Adam, Monnerie, Nathalie, Schmitz, Mark, Sattler, Christian, Cerri, Giovanni, de Maria, Giovanni, Giovanelli, Ambra, Orden, Alfrdo, de Lorenzo, Daniel, Cedillio, J., le Digou, Alain, Borgard, Jean-Marc, Roeb, M, Noglik, A, Monnerie, N, Schmitz, M, Sattler, C, Cerri, G, DE MARIA, G, Giovannelli, Ambra, Orden, A, DE LORENZO, D, Cedillo, J, LE DUIGOU, A, and Borgard, J. M.
- Subjects
Thermochemical Cycles ,Hydrogen - Published
- 2006
21. HYTHEC: Development of a dedicated solar receiver-reactor for the decomposition of sulphuric acid
- Author
-
Roeb, Martin, Noglik, Adam, Rietbrock, Peter-Michael, Mohr, Stefan, de Oliveira, Lamark, Sattler, Christian, Cerri, Giovanni, de Maria, Giovanni, Giovanelli, Ambra, Buenaventura, Arturo, de Lorenzo, Daniel, Roeb, M, Noglik, A, RIETBROCK P., M, Mohr, S, DE OLIVEIRA, L, Sattler, C, Cerri, G, DE MARIA, G, Giovannelli, Ambra, Buenaventura, A, and DE LORENZO, D.
- Subjects
thermochemical cycles ,nuclear ,hydrogen ,sulfur iodine ,HYTHEC ,solar - Published
- 2005
22. Genes Involved in Susceptibility to Obesity and Emotional Eating Behavior in a Romanian Population.
- Author
-
Vranceanu M, Filip L, Hegheș SC, de Lorenzo D, Cozma-Petruț A, Ghitea TC, Stroia CM, Banc R, Mîrza OM, Miere D, Cozma V, and Popa DS
- Subjects
- Humans, Romania epidemiology, Female, Male, Adult, Middle Aged, Body Mass Index, Alpha-Ketoglutarate-Dependent Dioxygenase FTO genetics, Genotype, Genome-Wide Association Study, Polymorphism, Single Nucleotide, Young Adult, Surveys and Questionnaires, Receptor, Melanocortin, Type 4 genetics, Feeding Behavior psychology, Obesity genetics, Obesity psychology, Genetic Predisposition to Disease, Emotions
- Abstract
Obesity, a significant public health concern with high prevalence in both adults and children, is a complex disorder arising from the interaction of multiple genes and environmental factors. Advances in genome-wide association studies (GWAS) and sequencing technologies have identified numerous polygenic causes of obesity, particularly genes involved in hunger, satiety signals, adipocyte differentiation, and energy expenditure. This study investigates the relationship between six obesity-related genes ( CLOCK, FTO, GHRL, LEP, LEPR, MC4R ) and their impact on BMI, WC, HC, WHR, and emotional eating behavior in 220 Romanian adults. Emotional eating was assessed using the validated Emotional Eating Questionnaire (EEQ). Our analysis revealed significant variability in obesity-related phenotypes and emotional eating behaviors across different genotypes. Specifically, CLOCK/ CC, FTO/ AA, and LEP/ AA genotypes were strongly associated with higher obesity metrics and emotional eating scores, while GHRL/ TT and MC4R/ CC were linked to increased BMI and WHR. The interplay between genetic predisposition and emotional eating behavior significantly influenced BMI and WHR, indicating a complex relationship between genetic and behavioral factors. This study, the first of its kind in Romania, provides a foundation for targeted interventions to prevent and reduce obesity and suggests potential strategies for gene expression modulation to mitigate the effects of emotional eating. Adopting a 'One Health' approach by creating an evidence base derived from both human and animal studies is crucial for understanding how to control obesity.
- Published
- 2024
- Full Text
- View/download PDF
23. Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial.
- Author
-
Ferreri AJM, Calimeri T, Ponzoni M, Curnis F, Conte GM, Scarano E, Rrapaj E, De Lorenzo D, Cattaneo D, Fallanca F, Nonis A, Foppoli M, Lopedote P, Citterio G, Politi LS, Sassone M, Angelillo P, Guggiari E, Steffanoni S, Tarantino V, Ciceri F, Bordignon C, Anzalone N, and Corti A
- Subjects
- Cyclophosphamide therapeutic use, Doxorubicin therapeutic use, Humans, Neoplasm Recurrence, Local, Prednisone therapeutic use, Recombinant Fusion Proteins, Rituximab, Tumor Necrosis Factor-alpha, Vincristine therapeutic use, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Endothelial Cells
- Abstract
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) is the standard treatment of diffuse large B-cell lymphoma (DLBCL). Primary DLBCL of the central nervous system (CNS) (primary central nervous system lymphoma [PCNSL]) is an exception because of the low CNS bioavailability of related drugs. NGR-human tumor necrosis factor (NGR-hTNF) targets CD13+ vessels, enhances vascular permeability and CNS access of anticancer drugs, and provides the rationale for the treatment of PCNSL with R-CHOP. Herein, we report activity and safety of R-CHOP preceded by NGR-hTNF in patients with PCNSL relapsed/refractory to high-dose methotrexate-based chemotherapy enrolled in a phase 2 trial. Overall response rate (ORR) was the primary endpoint. A sample size of 28 patients was considered necessary to demonstrate improvement from 30% to 50% ORR. NGR-hTNF/R-CHOP would be declared active if ≥12 responses were recorded. Treatment was well tolerated; there were no cases of unexpected toxicities, dose reductions or interruptions. NGR-hTNF/R-CHOP was active, with confirmed tumor response in 21 patients (75%; 95% confidence interval, 59%-91%), which was complete in 11. Seventeen of the 21 patients with response to treatment received consolidation (ASCT, WBRT, and/or lenalidomide maintenance). At a median follow-up of 21 (range, 14-31) months, 5 patients remained relapse-free and 6 were alive. The activity of NGR-hTNF/R-CHOP is in line with the expression of CD13 in both pericytes and endothelial cells of tumor vessels. High plasma levels of chromogranin A, an NGR-hTNF inhibitor, were associated with proton pump inhibitor use and a lower remission rate, suggesting that these drugs should be avoided during TNF-based therapy. Further research on this innovative approach to CNS lymphomas is warranted. The trial was registered as EudraCT: 2014-001532-11., (© 2020 by The American Society of Hematology.)
- Published
- 2020
- Full Text
- View/download PDF
24. Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
- Author
-
Ferreri AJM, Sassone M, Angelillo P, Zaja F, Re A, Di Rocco A, Spina M, Fabbri A, Stelitano C, Frezzato M, Volpetti S, Zambello R, Rusconi C, De Lorenzo D, Scarano E, Arcari A, Bertoldero G, Nonis A, Calimeri T, Perrone S, Cecchetti C, Tarantino V, Steffanoni S, Foppoli M, Ciceri F, and Ponzoni M
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Humans, Lymphoma, Large B-Cell, Diffuse pathology, Maintenance Chemotherapy, Male, Middle Aged, Neoplasm Recurrence, Local pathology, Prognosis, Survival Rate, Angiogenesis Inhibitors therapeutic use, Lenalidomide therapeutic use, Lymphoma, Large B-Cell, Diffuse drug therapy, Neoplasm Recurrence, Local drug therapy, Salvage Therapy
- Abstract
We report final results of a phase II trial addressing efficacy and feasibility of lenalidomide maintenance in patients with chemosensitive relapse of diffuse large B-cell lymphoma (DLBCL) not eligible for or failed after autologous stem cell transplantation (ASCT). Patients with relapsed DLBCL who achieved at least a partial response to salvage chemoimmunotherapy were enrolled and treated with lenalidomide 25 mg/day for 21 of 28 days for 2 years or until progression or unacceptable toxicity. Primary endpoint was 1-year PFS. Forty-six of 48 enrolled patients were assessable. Most patients had IPI ≥2, advanced stage and extranodal disease before the salvage treatment that led to trial registration; 28 (61%) patients were older than 70 years. Lenalidomide was well tolerated. With the exception of neutropenia, grade-4 toxicities occurred in <1% of courses. Three patients died of complications during maintenance and three died due to second cancers at 32 to 64 months. There were 13 SAEs recorded in 12 patients; all these patients but two recovered. Lenalidomide was interrupted due to toxicity in other 6 patients, and 25 patients required dose reduction (transient in 21). At 1 year from registration, 31 patients were progression free. After a median follow-up of 65 (range 39-124) months, 22 patients remain progression free, with a 5-year PFS of 48% ± 7%. The duration of response to lenalidomide was longer than response to prior treatment in 30 (65%) patients. Benefit was observed both in de novo and transformed DLBCL, germinal-center-B-cell and nongerminal-center-B-cell subtypes. Twenty-six patients are alive (5-year OS 62% ± 7%). With the limitations of a nonrandomized design, these long-term results suggest that lenalidomide maintenance might bring benefit to patients with chemosensitive relapse of DLBCL not eligible for or failed after ASCT. Lenalidomide was associated with durable disease control and was well tolerated in this elderly population. Further investigations on immunomodulatory drugs as maintenance in these high-risk patients are warranted., (© 2020 John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
25. Short-term high precision radiotherapy for early prostate cancer with concomitant boost to the dominant lesion: ad interim analysis and preliminary results of Phase II trial AIRC-IG-13218.
- Author
-
Timon G, Ciardo D, Bazani A, Marvaso G, Riva G, Volpe S, Rojas DP, Renne G, Petralia G, Zerini D, Fodor C, Dicuonzo S, Maestri D, Pansini F, Cambria R, Cattani F, Golino F, Scroffi V, De Lorenzo D, De Cobelli O, Orecchia R, and Jereczek-Fossa BA
- Subjects
- Aged, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, Prostate diagnostic imaging, Prostatic Neoplasms diagnostic imaging, Radiotherapy Dosage, Prostatic Neoplasms radiotherapy, Radiation Dose Hypofractionation, Radiotherapy, Computer-Assisted
- Abstract
Objective: To report preliminary results of a cutting edge extreme hypofractionated treatment with concomitant boost to the dominant lesion for patients with early stage prostate cancer (PCa)., Methods: AIRC-IG-13218 is a prospective Phase II trial started in June 2015. Patients with low and intermediate risk PCa who met the inclusion criteria underwent extreme hypofractionated radiotherapy to the prostate (36.25 Gy in 5 fractions) and a simultaneous integrated boost to the dominant intraprostatic lesion (DIL) to 37.5 Gy. The DIL was identified by a multiparamentric MRI (mpMRI) co-registered with planning CT. Toxicity was assessed according to CTCAE v4.0 and RTOG/EORTC criteria. The preliminary evaluation of the first 13 patients was required to confirm the feasibility of the treatment before completing the enrollment of 65 patients., Results: The first 13 patients completed the treatment between June 2015 and February 2016. With a median clinical follow-up of 17 months (range 11-26), no Grade 3 or 4 early toxicity was reported., Conclusions: Our preliminary data about early toxicity of an extreme hypofractionated schedule with concomitant boost on the DIL are encouraging. The higher number of patients expected for the trial and a longer follow-up are needed to confirm these results. Advances in knowledge: The use of mpMRI to identify and boost the DIL is an innovative and interesting approach to PCa. Our preliminary findings suggest that dose escalation using DIL boost and extremely hypofractionated radiotherapy regimens might be a safe approach, allowing for short and effective treatment of organ-confined PCa.
- Published
- 2018
- Full Text
- View/download PDF
26. Feasibility of lymphoscintigraphy for sentinel node identification after neo-adjuvant therapy.
- Author
-
Corso G, Grana CM, Gilardi L, Baio SM, De Lorenzo D, Maisonneuve P, Rotmensz N, Ballardini B, Lissidini G, Ratini S, Bassi FD, Veronesi P, and Galimberti V
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Anthracyclines administration & dosage, Anthracyclines pharmacology, Antineoplastic Agents pharmacology, Antineoplastic Agents, Hormonal pharmacology, Antineoplastic Agents, Hormonal therapeutic use, Antineoplastic Combined Chemotherapy Protocols pharmacology, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Breast Neoplasms surgery, Feasibility Studies, Female, Humans, Lymph Node Excision, Lymph Nodes diagnostic imaging, Lymph Nodes drug effects, Lymph Nodes pathology, Middle Aged, Radiopharmaceuticals, Retrospective Studies, Taxoids administration & dosage, Taxoids pharmacology, Technetium Tc 99m Aggregated Albumin, Young Adult, Antineoplastic Agents therapeutic use, Breast Neoplasms pathology, Lymphatic Metastasis diagnostic imaging, Lymphoscintigraphy, Neoadjuvant Therapy, Sentinel Lymph Node diagnostic imaging
- Abstract
Aim: To assess the sentinel-node identification rate at lymphoscintigraphy and its technical feasibility after neo-adjuvant treatments., Material of Study: Between 2000 and 2013, 444 consecutive patients affected by primary locally advanced breast cancer were enrolled in this study. All individuals were candidate for neo-adjuvant treatments and for lymphoscintigraphy before surgery., Results: The median age was 44 years at onset; almost one sentinel node was identified during lymphoscintigraphy in 430 cases. The detection rate at lymphoscintigraphy was 96.9% (95% CI, 94.8-98.1%). Considering the correlation between specific treatments and sentinel node identification rate, we verified that the detection rate did not vary significantly (p=0.53) according to the type of neo-adjuvant therapies administered to the patients., Conclusions: Our results demonstrated that lymphoscintigraphy for sentinel node identification is a safe and feasible procedure after neo-adjuvant therapies, independently of treatment types., Key Words: Breast Cancer, Neo-Adjuvant Treatment, Sentinel lymphnode biopsy, Lymphoscintigraphy.
- Published
- 2017
27. Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion.
- Author
-
Timon G, Ciardo D, Bazani A, Garioni M, Maestri D, De Lorenzo D, Pansini F, Cambria R, Rondi E, Cattani F, Marvaso G, Zerini D, Vischioni B, Ciocca M, Russo S, Molinelli S, Golino F, Scroffi V, Rojas DP, Fodor C, Petralia G, Santoro L, De Cobelli O, Orecchia R, and Jereczek-Fossa BA
- Subjects
- Biomarkers, Tumor, Dose Fractionation, Radiation, Humans, Image-Guided Biopsy, Magnetic Resonance Imaging, Male, Neoplasm Staging, Prognosis, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Clinical Protocols, Prostatic Neoplasms diagnosis, Prostatic Neoplasms radiotherapy, Radiation Dose Hypofractionation
- Abstract
Introduction: Of the different treatments for early prostate cancer, hypofractionated external-beam radiotherapy is one of the most interesting and studied options., Methods: The main objective of this phase II clinical study is to evaluate the feasibility, in terms of the incidence of acute side effects, of a new ultra-hypofractionated scheme for low- or intermediate-risk prostate cancer patients treated with the latest imaging and radiotherapy technology, allowing dose escalation to the dominant intraprostatic lesion identified by multiparametric magnetic resonance imaging. Secondary endpoints of the study are the evaluation of the long-term tolerability of the treatment in terms of late side effects, quality of life, and efficacy (oncological outcome)., Results: The study is ongoing, and we expect to complete recruitment by the end of 2016., Conclusions: Like in previous studies, we expect ultra-hypofractionated radiation treatment for prostate cancer to be well tolerated and effective., Trial Registration: ClinicalTrials.gov identifier: NCT01913717.
- Published
- 2016
- Full Text
- View/download PDF
28. A genetic-based algorithm for personalized resistance training.
- Author
-
Jones N, Kiely J, Suraci B, Collins DJ, de Lorenzo D, Pickering C, and Grimaldi KA
- Abstract
Association studies have identified dozens of genetic variants linked to training responses and sport-related traits. However, no intervention studies utilizing the idea of personalised training based on athlete's genetic profile have been conducted. Here we propose an algorithm that allows achieving greater results in response to high- or low-intensity resistance training programs by predicting athlete's potential for the development of power and endurance qualities with the panel of 15 performance-associated gene polymorphisms. To develop and validate such an algorithm we performed two studies in independent cohorts of male athletes (study 1: athletes from different sports (n = 28); study 2: soccer players (n = 39)). In both studies athletes completed an eight-week high- or low-intensity resistance training program, which either matched or mismatched their individual genotype. Two variables of explosive power and aerobic fitness, as measured by the countermovement jump (CMJ) and aerobic 3-min cycle test (Aero3) were assessed pre and post 8 weeks of resistance training. In study 1, the athletes from the matched groups (i.e. high-intensity trained with power genotype or low-intensity trained with endurance genotype) significantly increased results in CMJ (P = 0.0005) and Aero3 (P = 0.0004). Whereas, athletes from the mismatched group (i.e. high-intensity trained with endurance genotype or low-intensity trained with power genotype) demonstrated non-significant improvements in CMJ (P = 0.175) and less prominent results in Aero3 (P = 0.0134). In study 2, soccer players from the matched group also demonstrated significantly greater (P < 0.0001) performance changes in both tests compared to the mismatched group. Among non- or low responders of both studies, 82% of athletes (both for CMJ and Aero3) were from the mismatched group (P < 0.0001). Our results indicate that matching the individual's genotype with the appropriate training modality leads to more effective resistance training. The developed algorithm may be used to guide individualised resistance-training interventions.
- Published
- 2016
- Full Text
- View/download PDF
29. Vitamin D receptor BsmI polymorphism modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease risk factors profile.
- Author
-
Serrano JC, De Lorenzo D, Cassanye A, Martín-Gari M, Espinel A, Delgado MA, Pamplona R, and Portero-Otin M
- Abstract
Vitamin D receptor polymorphisms may predispose that not all individuals could have benefits from the nutritional supplementation of 25-hydroxyvitamin D. Furthermore, vitamin D-related cardiovascular effects may also be influenced by soy isoflavones considered endocrine regulators of cardiovascular homeostasis. To find possible gene-diet interactions by evaluating individualized lipid metabolism benefits from an increase in soy and 25-hydroxyvitamin D intake, 106 healthy individuals, genotyped for vitamin D receptor (VDR) gene polymorphism rs1544410 (BsmI) were randomly assigned to either no intake, to daily 250 mL or 500 mL of a 25-hydroxyvitamin D supplemented SB for 2 months. The soybean beverage induced differences in cardiovascular risk factors (lipid profile, blood pressure, TNFα and MCP-1), as well as vitamin D metabolites in a dose-gene-dependent relation. Thus, VDR BsmI polymorphism affected individual response being the GG genotype the ones that showed dose-dependent manner responsiveness in the reduction in total cholesterol, LDL and triglycerides in comparison with the AA/AG genotype. These differences were associated with increased plasma levels of 1α,25-dyhydroxyvitamin D3 in the carriers of the GG genotype. It was concluded that metabolic response to 25-hydroxyvitamin D and soybean supplementation is dependent on VDR BsmI GG genotype due to a higher conversion rate from vitamin D precursors.
- Published
- 2013
- Full Text
- View/download PDF
30. Intraoperative forces and moments analysis on patient head clamp during awake brain surgery.
- Author
-
De Lorenzo D, De Momi E, Conti L, Votta E, Riva M, Fava E, Bello L, and Ferrigno G
- Subjects
- Biomechanical Phenomena physiology, Humans, Movement, Posture, Restraint, Physical instrumentation, Surgical Instruments, Brain surgery, Head physiology, Head surgery, Neurosurgical Procedures instrumentation, Neurosurgical Procedures methods, Restraint, Physical methods, Signal Processing, Computer-Assisted, Wakefulness
- Abstract
In brain surgery procedures, such as deep brain stimulation, drug-resistant epilepsy and tumour surgery, the patient is intentionally awakened to map functional neural bases via electrophysiological assessment. This assessment can involve patient's body movements; thus, increasing the mechanical load on the head-restraint systems used for keeping the skull still during the surgery. The loads exchanged between the head and the restraining device can potentially result into skin and bone damage. The aim of this work is to assess such loads for laying down the requirements of a surgical robotics system for dynamic head movements compensation by fast moving arms and by an active restraint able to damp such actions. A Mayfield(®) head clamp was tracked and instrumented with strain gages (SGs). SG locations were chosen according to finite element analyses. During an actual brain surgery, displacements and strains were measured and clustered according to events that generated them. Loads were inferred from strain data. The greatest force components were exerted vertically (median 5.5 N, maximum 151.87 N) with frequencies up to 1.5 Hz. Maximum measured displacement and velocity were 9 mm and 60 mm/s, with frequencies up to 2.8 Hz. The analysis of loads and displacements allowed to identify the surgery steps causing maximal loads on the head-restraint device.
- Published
- 2013
- Full Text
- View/download PDF
31. Coaxial needle insertion assistant with enhanced force feedback.
- Author
-
De Lorenzo D, Koseki Y, De Momi E, Chinzei K, and Okamura AM
- Subjects
- Biomechanical Phenomena, Brain physiology, Computer Simulation, Feedback, Humans, Models, Biological, Pressure, Surgery, Computer-Assisted, Minimally Invasive Surgical Procedures instrumentation, Minimally Invasive Surgical Procedures methods, Needles, Robotics instrumentation, Signal Processing, Computer-Assisted
- Abstract
Many medical procedures involving needle insertion into soft tissues, such as anesthesia, biopsy, brachytherapy, and placement of electrodes, are performed without image guidance. In such procedures, haptic detection of changing tissue properties at different depths during needle insertion is important for needle localization and detection of subsurface structures. However, changes in tissue mechanical properties deep inside the tissue are difficult for human operators to sense, because the relatively large friction force between the needle shaft and the surrounding tissue masks the smaller tip forces. A novel robotic coaxial needle insertion assistant, which enhances operator force perception, is presented. This one-degree-of-freedom cable-driven robot provides to the operator a scaled version of the force applied by the needle tip to the tissue, using a novel design and sensors that separate the needle tip force from the shaft friction force. The ability of human operators to use the robot to detect membranes embedded in artificial soft tissue was tested under the conditions of 1) tip force and shaft force feedback, and 2) tip force only feedback. The ratio of successful to unsuccessful membrane detections was significantly higher (up to 50%) when only the needle tip force was provided to the user.
- Published
- 2013
- Full Text
- View/download PDF
32. Coaxial needle insertion assistant for epidural puncture effect of lateral force on needle.
- Author
-
Koseki Y, Kawai M, De Lorenzo D, Yamauchi Y, and Chinzei K
- Subjects
- Humans, Injections, Epidural instrumentation, Injections, Epidural methods, Motion, Needles, Robotics instrumentation, Robotics methods
- Abstract
We validated the effectiveness of a coaxial needle insertion assistant under the condition that the needles were laterally deformed. The coaxial needle insertion assistant separates the cutting force at the needle tip from shear friction on the needle shaft, and haptically display it to a user in order to assists her/his perception during epidural puncture. An outer needle covers the side of an inner needle, preventing the shear friction from acting on the inner needle. However when the needles are laterally deformed and make contact to each other, it is concerned that the effect of the separation is degraded. In this paper, the users punctured an artificial tissue with variable insertion angles, so that the needle is intentionally laterally deformed. The overshoot and user confidence in detecting puncture was examined.
- Published
- 2013
- Full Text
- View/download PDF
33. Accurate calibration method for 3D freehand ultrasound probe using virtual plane.
- Author
-
De Lorenzo D, Vaccarella A, Khreis G, Moennich H, Ferrigno G, and De Momi E
- Subjects
- Calibration, Equipment Design, Equipment Failure Analysis, Image Enhancement methods, Image Enhancement standards, Image Interpretation, Computer-Assisted standards, Imaging, Three-Dimensional standards, Italy, Reproducibility of Results, Sensitivity and Specificity, Ultrasonography standards, Algorithms, Image Enhancement instrumentation, Image Interpretation, Computer-Assisted instrumentation, Imaging, Three-Dimensional methods, Phantoms, Imaging, Transducers, Ultrasonography instrumentation
- Abstract
Purpose: In this paper a new, easy-to-manufacture and easy-to-use ultrasound (US) probe calibration phantom for 3D freehand scanning is presented and evaluated, together with a new method for achieving an accurate and user-robust calibration using virtual plane., Methods: The phantom allows the optically tracked US probe to perform two rotations and two translations while keeping the image of a tensioned wire in the image plane. This approach allows obtaining a sharp image of the wire independently from the probe pose. The virtual plane allows the calibration algorithm to converge minimizing the required number of US probe tracked poses. The US image and position data are synchronized via a CORBA interface, created within the Image Guided Surgery Toolkit (IGSTK) framework. The calibration algorithm and the calibration protocol were evaluated in a set of experiments carried out by different test-users., Results: The calibration method proved to be accurate and precise: 3D point reconstruction accuracy resulted 0.2 mm as mean value, while the precision was 0.4 mm as standard deviation., Conclusions: The technique showed to be suitable for medical applications from morphological diagnosis to intraoperative surgical planning adaption.
- Published
- 2011
- Full Text
- View/download PDF
34. Force feedback in a piezoelectric linear actuator for neurosurgery.
- Author
-
De Lorenzo D, De Momi E, Dyagilev I, Manganelli R, Formaglio A, Prattichizzo D, Shoham M, and Ferrigno G
- Subjects
- Biopsy instrumentation, Biopsy methods, Brain pathology, Computer Simulation, Equipment Design, Humans, Microsurgery instrumentation, Minimally Invasive Surgical Procedures, Psychophysics, Reproducibility of Results, Stress, Mechanical, Surgery, Computer-Assisted instrumentation, User-Computer Interface, Feedback, Neurosurgical Procedures instrumentation, Robotic Surgical Procedures instrumentation
- Abstract
Background: Force feedback in robotic minimally invasive surgery allows the human operator to manipulate tissues as if his/her hands were in contact with the patient organs. A force sensor mounted on the probe raises problems with sterilization of the overall surgical tool. Also, the use of off-axis gauges introduces a moment that increases the friction force on the bearing, which can easily mask off the signal, given the small force to be measured., Methods: This work aims at designing and testing two methods for estimating the resistance to the advancement (force) experienced by a standard probe for brain biopsies within a brain-like material. The further goal is to provide a neurosurgeon using a master-slave tele-operated driver with direct feedback on the tissue mechanical characteristics. Two possible sensing methods, in-axis strain gauge force sensor and position-position error (control-based method), were implemented and tested, both aimed at device miniaturization. The analysis carried out was aimed at fulfilment of the psychophysics requirements for force detection and delay tolerance, also taking into account safety, which is directly related to the last two issues. Controller parameters definition is addressed and consideration is given to development of the device with integration of a haptic interface., Results: Results show better performance of the control-based method (RMSE < 0.1 N), which is also best for reliability, sterilizability, and material dimensions for the application addressed., Conclusions: The control-based method developed for force estimation is compatible with the neurosurgical application and is also capable of measuring tissue resistance without any additional sensors. Force feedback in minimally invasive surgery allows the human operator to manipulate tissues as if his/her hands were in contact with the patient organs., (Copyright © 2011 John Wiley & Sons, Ltd.)
- Published
- 2011
- Full Text
- View/download PDF
35. Experimental evaluation of a coaxial needle insertion assistant with enhanced force feedback.
- Author
-
De Lorenzo D, Koseki Y, De Momi E, Chinzei K, and Okamura AM
- Subjects
- Equipment Design, Humans, Robotics, Needles, Pressure
- Abstract
During needle insertion in soft tissue, detection of change in tissue properties is important both for diagnosis to detect pathological tissue and for prevention to avoid puncture of important structures. The presence of a membrane located deep inside the tissue results in a relatively small force variation at the needle tip that can be masked by relatively large friction force between the needle shaft and the surrounding tissue. Also, user perception of force can be limited due to the overall small force amplitude in some applications (e.g. brain surgery). A novel robotic coaxial needle insertion assistant was developed to enhance operator force perception. The coaxial needle separates the cutting force at the needle tip from shear friction on the needle shaft. The assistant is force controlled (admittance control), providing the operator with force feedback that is a scaled version of the force applied by the needle tip to the tissue. The effectiveness of the assistant in enhancing the detection of different tissue types was tested experimentally. Users were asked to blindly insert a needle into artificial tissues with membranes at various depths under two force feedback conditions: (1) shaft and tip force together, and (2) only tip force. The ratio of successful to unsuccessful membrane detection was significantly higher when only the needle tip force is displayed to the user. The system proved to be compliant with the clinical applications requirements.
- Published
- 2011
- Full Text
- View/download PDF
36. Distinctly different sex ratios in African and European populations of Drosophila melanogaster inferred from chromosomewide single nucleotide polymorphism data.
- Author
-
Hutter S, Li H, Beisswanger S, De Lorenzo D, and Stephan W
- Subjects
- Africa, Animals, Chromosome Inversion, Demography, Europe, Female, Genetics, Population, Likelihood Functions, Linkage Disequilibrium, Male, Selection, Genetic, Drosophila melanogaster genetics, Genetic Linkage, Genetic Variation, Polymorphism, Single Nucleotide genetics, Sex Ratio, X Chromosome
- Abstract
It has been hypothesized that the ratio of X-linked to autosomal sequence diversity is influenced by unequal sex ratios in Drosophila melanogaster populations. We conducted a genome scan of single nucleotide polymorphism (SNP) of 378 autosomal loci in a derived European population and of a subset of 53 loci in an ancestral African population. On the basis of these data and our already available X-linked data, we used a coalescent-based maximum-likelihood method to estimate sex ratios and demographic histories simultaneously for both populations. We confirm our previous findings that the African population experienced a population size expansion while the European population suffered a population size bottleneck. Our analysis also indicates that the female population size in Africa is larger than or equal to the male population size. In contrast, the European population shows a huge excess of males. This unequal sex ratio and the bottleneck alone, however, cannot account for the overly strong decrease of X-linked diversity in the European population (compared to the reduction on the autosome). The patterns of the frequency spectrum and the levels of linkage disequilibrium observed in Europe suggest that, in addition, positive selection must have acted in the derived population.
- Published
- 2007
- Full Text
- View/download PDF
37. Contrasting patterns of sequence divergence and base composition between Drosophila introns and intergenic regions.
- Author
-
Ometto L, De Lorenzo D, and Stephan W
- Subjects
- Animals, Base Composition genetics, Evolution, Molecular, Introns genetics, Mutation genetics, Sequence Analysis, DNA veterinary, Statistics as Topic, DNA, Intergenic genetics, Drosophila genetics, Genetic Variation
- Abstract
Two non-coding DNA classes, introns and intergenic regions, of Drosophila melanogaster exhibit contrasting evolutionary patterns. GC content is significantly higher in intergenic regions and affects their degree of nucleotide variability. Divergence is positively correlated with recombination rate in intergenic regions, but not in introns. We argue that these differences are due to different selective constraints rather than mutational or recombinational mechanisms.
- Published
- 2006
- Full Text
- View/download PDF
38. Evidence of gene conversion associated with a selective sweep in Drosophila melanogaster.
- Author
-
Glinka S, De Lorenzo D, and Stephan W
- Subjects
- Africa, Animals, Base Sequence, DNA genetics, Europe, Genes, Insect, Genetic Variation, Genetics, Population, Haplotypes, Linkage Disequilibrium, Models, Genetic, Mutation, Selection, Genetic, Sequence Alignment, X Chromosome genetics, Drosophila melanogaster genetics, Evolution, Molecular, Gene Conversion
- Abstract
Since Drosophila melanogaster colonized Europe from tropical Africa 10 to 15 thousand years ago, it is expected that adaptation has played a major role in this species in recent times. A previously conducted multilocus scan of noncoding DNA sequences on the X chromosome in an ancestral and a derived population of D. melanogaster revealed that some loci have been affected by directional selection in the European population. We investigated if the pattern of DNA sequence polymorphism in a region surrounding one of these loci can be explained by a hitchhiking event. We found strong evidence that the studied region around the gene unc-119 was shaped by a recent selective sweep, including a valley of reduced heterozygosity of 83.4 kb, a skew in the frequency spectrum, and significant linkage disequilibrium on one side of the valley. This region, however, was interrupted by gene conversion events leading to a strong haplotype structure in the center of the valley of reduced variation.
- Published
- 2006
- Full Text
- View/download PDF
39. Evidence for a selective sweep in the wapl region of Drosophila melanogaster.
- Author
-
Beisswanger S, Stephan W, and De Lorenzo D
- Subjects
- Africa, Animals, Chromosome Segregation, Europe, Geography, Haplotypes genetics, Linkage Disequilibrium, X Chromosome genetics, Drosophila Proteins genetics, Drosophila melanogaster genetics, Genome, Polymorphism, Genetic, Selection, Genetic
- Abstract
A scan of the X chromosome of a European Drosophila melanogaster population revealed evidence for the recent action of positive directional selection at individual loci. In this study we analyze one such region that showed no polymorphism in the genome scan (located in cytological division 2C10-2E1). We detect a 60.5-kb stretch of DNA encompassing the genes ph-d, ph-p, CG3835, bcn92, Pgd, wapl, and Cyp4d1, which almost completely lacks variation in the European sample. Loci flanking this region show a skewed frequency spectrum at segregating sites, strong haplotype structure, and high levels of linkage disequilibrium. Neutrality tests reveal that these data are unlikely under both the neutral equilibrium model and the simple bottleneck scenarios. In contrast, newly developed maximum-likelihood ratio tests suggest that strong selection has acted recently on the region under investigation, causing a selective sweep. Evidence that this sweep may have originated in an ancestral population in Africa is presented.
- Published
- 2006
- Full Text
- View/download PDF
40. Inferring the effects of demography and selection on Drosophila melanogaster populations from a chromosome-wide scan of DNA variation.
- Author
-
Ometto L, Glinka S, De Lorenzo D, and Stephan W
- Subjects
- Africa, Animals, Base Sequence, Demography, Europe, Evolution, Molecular, Population, Telomere genetics, DNA genetics, Drosophila melanogaster classification, Drosophila melanogaster genetics, Genetic Variation, Selection, Genetic
- Abstract
Identifying regions of the Drosophila melanogaster genome that have been recent targets of positive Darwinian selection will provide evidence for adaptations that have helped this species to colonize temperate habitats. We have begun a search for such genomic regions by analyzing multiple loci (about 250) dispersed across the X chromosome in a putatively ancestral population from East Africa and a derived European population. For both populations we found evidence for past changes in population size. We estimated that a major bottleneck associated with the colonization of Europe occurred about 3,500-16,000 years ago. We also found that while this bottleneck can account for most of the reduction in variation observed in the European sample, there is a deficit of polymorphism in some genomic regions that cannot be explained by demography alone.
- Published
- 2005
- Full Text
- View/download PDF
41. Insertion/deletion and nucleotide polymorphism data reveal constraints in Drosophila melanogaster introns and intergenic regions.
- Author
-
Ometto L, Stephan W, and De Lorenzo D
- Subjects
- Animals, Models, Genetic, Species Specificity, DNA Transposable Elements, Drosophila melanogaster genetics, Introns, Polymorphism, Genetic, Sequence Deletion
- Abstract
Our study of nucleotide sequence and insertion/deletion polymorphism in Drosophila melanogaster noncoding DNA provides evidence for selective pressures in both intergenic regions and introns (of the large size class). Intronic and intergenic sequences show a similar polymorphic deletion bias. Insertions have smaller sizes and higher frequencies than deletions, supporting the hypothesis that insertions are selected to compensate for the loss of DNA caused by deletion bias. Analysis of a simple model of selective constraints suggests that the blocks of functional elements located in intergenic sequences are on average larger than those in introns, while the length distribution of relatively unconstrained sequences interspaced between these blocks is similar in intronic and intergenic regions.
- Published
- 2005
- Full Text
- View/download PDF
42. Demography and natural selection have shaped genetic variation in Drosophila melanogaster: a multi-locus approach.
- Author
-
Glinka S, Ometto L, Mousset S, Stephan W, and De Lorenzo D
- Subjects
- Animals, Polymerase Chain Reaction, Polymorphism, Genetic, Recombination, Genetic, X Chromosome, Drosophila melanogaster genetics, Selection, Genetic
- Abstract
Demography and selection have been recognized for their important roles in shaping patterns of nucleotide variability. To investigate the relative effects of these forces in the genome of Drosophila melanogaster, we used a multi-locus scan (105 fragments) of X-linked DNA sequence variation in a putatively ancestral African and a derived European population. Surprisingly, we found evidence for a recent size expansion in the African population, i.e., a significant excess of singletons at a chromosome-wide level. In the European population, such an excess was not detected. In contrast to the African population, we found evidence for positive natural selection in the European sample: (i) a large number of loci with low levels of variation and (ii) a significant excess of derived variants at the low-variation loci that are fixed in the European sample but rare in the African population. These results are consistent with the hypothesis that the European population has experienced frequent selective sweeps in the recent past during its adaptation to new habitats. Our study shows the advantages of a genomic approach (over a locus-specific analysis) in disentangling demographic and selective forces.
- Published
- 2003
- Full Text
- View/download PDF
43. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection.
- Author
-
Hoe NP, Vuopio-Varkila J, Vaara M, Grigsby D, De Lorenzo D, Fu YX, Dou SJ, Pan X, Nakashima K, and Musser JM
- Subjects
- Alleles, Amino Acid Sequence, Bacteremia microbiology, Bacterial Proteins chemistry, Bacterial Proteins metabolism, Carrier Proteins chemistry, Carrier Proteins genetics, Complement Inactivator Proteins genetics, Complement Inactivator Proteins metabolism, Finland epidemiology, Gene Expression Regulation, Bacterial, Humans, Molecular Sequence Data, Pharyngitis microbiology, Phylogeny, Population Surveillance, Serotyping, Streptococcal Infections microbiology, Streptococcus pyogenes classification, Streptococcus pyogenes genetics, Streptococcus pyogenes metabolism, Virulence genetics, Antigens, Bacterial, Bacteremia epidemiology, Bacterial Outer Membrane Proteins, Bacterial Proteins genetics, Disease Outbreaks, Pharyngitis epidemiology, Streptococcal Infections epidemiology, Streptococcus pyogenes pathogenicity
- Abstract
Streptococcal inhibitor of complement (Sic) is a highly polymorphic extracellular protein made predominantly by serotype M1 group A Streptococcus (GAS). New variants of the Sic protein frequently appear in M1 epidemics as a result of positive natural selection. To gain further understanding of the molecular basis of M1 epidemics, the sic gene was sequenced from 471 pharyngitis and 127 pyogenic and blood isolates recovered from 598 patients living in metropolitan Helsinki, Finland, during a 37-month population-based surveillance study. Most M1 GAS subclones recovered from pyogenic infections and blood were abundantly represented in the pool of subclones causing pharyngitis. Alleles shared among the pharyngitis, pyogenic, and blood samples were identified in throat isolates a mean of 9.8 months before their recovery from pyogenic infections and blood, which indicates that selection of most sic variants occurs on mucosal surfaces. In contrast, no variation was identified in the emm and covR/covS genes.
- Published
- 2001
- Full Text
- View/download PDF
44. Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves.
- Author
-
Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P, Dou SJ, Pan X, Vuopio-Varkila J, Salmelinna S, McGeer A, Low DE, Schwartz B, Schuchat A, Naidich S, De Lorenzo D, Fu YX, and Musser JM
- Subjects
- Animals, Antigenic Variation genetics, Canada, Carrier Proteins genetics, Chromosomes, Bacterial genetics, Complement Hemolytic Activity Assay, Finland, Mice, Mucous Membrane microbiology, Pharyngitis microbiology, Phylogeny, Streptococcus pyogenes immunology, Streptococcus pyogenes isolation & purification, United States, Antigens, Bacterial, Bacterial Outer Membrane Proteins, Bacterial Proteins genetics, Complement Inactivator Proteins genetics, Disease Outbreaks, Streptococcal Infections epidemiology, Streptococcus pyogenes genetics
- Abstract
Serotype M1 group A Streptococcus strains cause epidemic waves of human infections long thought to be mono- or pauciclonal. The gene encoding an extracellular group A Streptococcus protein (streptococcal inhibitor of complement) that inhibits human complement was sequenced in 1,132 M1 strains recovered from population-based surveillance of infections in Canada, Finland and the United States. Epidemic waves are composed of strains expressing a remarkably heterogeneous array of variants of streptococcal inhibitor of complement that arise very rapidly by natural selection on mucosal surfaces. Thus, our results enhance the understanding of pathogen population dynamics in epidemic waves and infectious disease reemergence.
- Published
- 1999
- Full Text
- View/download PDF
45. Ovarian influence on adrenal androgen secretion in polycystic ovary syndrome.
- Author
-
Fruzzetti F, De Lorenzo D, Ricci C, and Teti G
- Subjects
- Adolescent, Adult, Androgens blood, Cosyntropin pharmacology, Dexamethasone pharmacology, Female, Gonadotropin-Releasing Hormone agonists, Humans, Hyperandrogenism blood, Hyperandrogenism etiology, Hyperandrogenism physiopathology, Peptide Fragments pharmacology, Polycystic Ovary Syndrome complications, Polycystic Ovary Syndrome metabolism, Adrenal Glands metabolism, Androgens metabolism, Ovary physiopathology, Polycystic Ovary Syndrome physiopathology
- Abstract
Objective: To determine whether the ovary influences adrenal androgen secretion in polycystic ovary syndrome (PCOS)., Design: The adrenal androgen secretion was evaluated before and during ovarian suppression with a long-acting GnRH agonist., Setting: Department of Obstetrics and Gynecology, Pisa, Italy., Participants: Women with PCOS and high (10 subjects) and normal (12 subjects) DHEAS levels and 6 normal women., Interventions: After 1 mg dexamethasone, an ACTH-(1-24) stimulation test was performed in the early follicular phase of the menstrual cycle. The test was repeated after two injections of a long-acting GnRH analogue (GnRH-a)., Main Outcome Measures: Basal plasma levels of gonadotropins, E2, T, androstenedione (A), 17 alpha-hydroxyprogesterone (17-OHP), DHEAS, and cortisol (F) were evaluated before the evening administration of dexamethasone. Serum A, T, 17-OHP, DHEAS, and F were measured 9 hours after dexamethasone and in samples collected 60 and 120 minutes after ACTH IV injection., Results: In the high DHEAS group the maximum increases in T, A, 17-OHP, and DHEAS in response to ACTH were significantly higher than in normal DHEAS PCOS women and in normal women. The GnRH-a modified the A and T responses to ACTH in the high DHEAS group., Conclusions: Ovarian steroids, or other extra-ovarian factors, seem to be responsible for the increased A and T responses to the corticotropin stimulation demonstrated in some PCOS women.
- Published
- 1995
- Full Text
- View/download PDF
46. Clinical and endocrine effects of flutamide in hyperandrogenic women.
- Author
-
Fruzzetti F, De Lorenzo D, Ricci C, and Fioretti P
- Subjects
- 17-alpha-Hydroxyprogesterone, Adolescent, Adult, Androgens blood, Estradiol blood, Female, Follicle Stimulating Hormone blood, Gonadotropin-Releasing Hormone, Hair drug effects, Hair growth & development, Hirsutism blood, Humans, Hydrocortisone blood, Hydroxyprogesterones blood, Luteinizing Hormone blood, Menstruation blood, Menstruation drug effects, Menstruation Disturbances blood, Progesterone blood, Prolactin blood, Sex Hormone-Binding Globulin analysis, Flutamide, Hirsutism drug therapy, Hormones blood, Menstruation Disturbances drug therapy
- Abstract
Objective: To investigate the clinical and endocrine effects of the antiandrogen flutamide in hirsute women., Design: Hirsutism was assessed before and after 3 months of treatment with flutamide 500 mg/d. Endocrine evaluations were performed before and during the 2nd month of treatment with flutamide 500 mg or 750 mg/d., Setting: Department of Obstetrics and Gynecology, Pisa, Italy., Participants: Eighteen hirsute women were studied: nine women were hyperandrogenic, and the other 9 had an idiopathic hirsutism., Interventions: Women were randomly treated with flutamide 500 mg/d (9 patients) or 750 mg/d (9 patients) for 3 and 2 months, respectively. Six received placebo 1 month before flutamide treatment., Main Outcome Measures: Hirsutism was assessed by measuring hair diameter. Follicle-stimulating hormone and LH responses to GnRH were evaluated. Basal plasma levels of T, androstenedione (A), 17-hydroxyprogesterone (17-OHP), DHEAS, cortisol (F), and sex hormone-binding globulin (SHBG) were evaluated. The same hormones were determined after a single dose of flutamide (250 or 500 mg) or placebo throughout a 12-hour period and in samples collected 60 and 120 minutes after ACTH intravenous injection., Results: Hair diameter was reduced by 30%. Both dosages of flutamide did not change basal and stimulated gonadotropin, T, A, 17-OHP, F, and SHBG levels. Both dosages reduced stimulated DHEAS levels., Conclusions: Flutamide may have a beneficial effect on hirsutism. This effectiveness is mainly due to its peripheral antiandrogen action. However, an effect on the adrenal gland seems to be present.
- Published
- 1993
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.